These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7981992)
21. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate. O'Dell JR Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S53-8. PubMed ID: 10589358 [TBL] [Abstract][Full Text] [Related]
22. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Gubar' EE; Bochkova AG; Bunchuk NV Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110 [TBL] [Abstract][Full Text] [Related]
23. Treatment continuation rate in relation to efficacy and toxicity in long-term therapy with low-dose methotrexate, sulfasalazine, and bucillamine in 1,358 Japanese patients with rheumatoid arthritis. Nagashima M; Matsuoka T; Saitoh K; Koyama T; Kikuchi O; Yoshino S Clin Exp Rheumatol; 2006; 24(3):260-7. PubMed ID: 16870092 [TBL] [Abstract][Full Text] [Related]
24. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial. Huang RY; Pan HD; Wu JQ; Zhou H; Li ZG; Qiu P; Zhou YY; Chen XM; Xie ZX; Xiao Y; Huang QC; Liu L Phytomedicine; 2019 Apr; 57():403-410. PubMed ID: 30851515 [TBL] [Abstract][Full Text] [Related]
25. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382 [TBL] [Abstract][Full Text] [Related]
26. Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugs. Schipper LG; Fransen J; Barrera P; Van Riel PL Rheumatology (Oxford); 2009 Jul; 48(7):828-33. PubMed ID: 19458163 [TBL] [Abstract][Full Text] [Related]
27. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region. Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474 [TBL] [Abstract][Full Text] [Related]
28. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ; Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331 [TBL] [Abstract][Full Text] [Related]
29. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. St Clair EW; van der Heijde DM; Smolen JS; Maini RN; Bathon JM; Emery P; Keystone E; Schiff M; Kalden JR; Wang B; Dewoody K; Weiss R; Baker D; Arthritis Rheum; 2004 Nov; 50(11):3432-43. PubMed ID: 15529377 [TBL] [Abstract][Full Text] [Related]
30. Randomized, double-blind, placebo-controlled, comparative study of human anti-TNF antibody adalimumab in combination with methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis. Chen DY; Chou SJ; Hsieh TY; Chen YH; Chen HH; Hsieh CW; Lan JL J Formos Med Assoc; 2009 Apr; 108(4):310-9. PubMed ID: 19369178 [TBL] [Abstract][Full Text] [Related]
31. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520 [TBL] [Abstract][Full Text] [Related]
32. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group. Stein CM; Pincus T; Yocum D; Tugwell P; Wells G; Gluck O; Kraag G; Torley H; Tesser J; McKendry R; Brooks RH Arthritis Rheum; 1997 Oct; 40(10):1843-51. PubMed ID: 9336420 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoïde Artritis. Verhoeven AC; Bibo JC; Boers M; Engel GL; van der Linden S Br J Rheumatol; 1998 Oct; 37(10):1102-9. PubMed ID: 9825750 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy. Li Z; Zhang F; Kay J; Fei K; Han C; Zhuang Y; Wu Z; Hsia EC Int J Rheum Dis; 2016 Nov; 19(11):1143-1156. PubMed ID: 26259617 [TBL] [Abstract][Full Text] [Related]
35. Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study. Schoels M; Kapral T; Stamm T; Smolen JS; Aletaha D Ann Rheum Dis; 2007 Aug; 66(8):1059-65. PubMed ID: 17307765 [TBL] [Abstract][Full Text] [Related]
36. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189 [TBL] [Abstract][Full Text] [Related]
37. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005 [TBL] [Abstract][Full Text] [Related]
38. Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis. Bonafede M; Johnson BH; Tang DH; Shah N; Harrison DJ; Collier DH Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1656-63. PubMed ID: 26097194 [TBL] [Abstract][Full Text] [Related]
39. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review. Mary J; De Bandt M; Lukas C; Morel J; Combe B J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710 [TBL] [Abstract][Full Text] [Related]
40. [Basic therapy of rheumatoid arthritis. Comparison of methotrexate and sulfasalazine]. Keitel W; Keitel R; Pap T Z Gesamte Inn Med; 1993 Oct; 48(10):480-3. PubMed ID: 7903012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]